Metraipolis › archive › dc_a3d4bc86c433

Assessment of methylated BCAT1 and IKZF1 circulating tumor DNA as a prognostic biomarker in esophagogastric adenocarcinomas — Europe PMC PMID:42149660

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42149660
DOI: 10.1093/dote/doag048
License (as archived): solo-consultazione
Archived: 2026-11-02T20:26:56.477Z
SHA-256 of the archived text: 69365b8cb3f29aa2f055646d26ba12a77cf74a8c493f4644b53aba1ebe7cd2a1
Stable URL of this page: https://metraipolis.com/documento/dc_a3d4bc86c433

How to cite

Assessment of methylated BCAT1 and IKZF1 circulating tumor DNA as a prognostic biomarker in esophagogastric adenocarcinomas — Europe PMC PMID:42149660 — Europe PMC (en), https://europepmc.org/article/MED/42149660 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a3d4bc86c433 (Metraipolis archive dc_a3d4bc86c433, sha256 69365b8cb3f29aa2f055646d26ba12a77cf74a8c493f4644b53aba1ebe7cd2a1)

BibTeX

@misc{dca3d4bc86c433,
  title = {Assessment of methylated BCAT1 and IKZF1 circulating tumor DNA as a prognostic biomarker in esophagogastric adenocarcinomas — Europe PMC PMID:42149660},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42149660},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a3d4bc86c433; sha256 69365b8cb3f29aa2f055646d26ba12a77cf74a8c493f4644b53aba1ebe7cd2a1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42149660. Agents can read the archived copy with the MCP tool read_document.